Comparison tool

Compare peptides

Pick up to three compounds. Useful for deciding whether two peptides in a stack actually do different things, or whether you're paying twice for the same pathway.

Select up to three (1/3)

Comparison results

Attribute
CategoryGrowth hormone
Evidence gradeModerate
Also known asNNC 26-0161
MechanismActs as a ghrelin receptor (GHS-R1a) agonist on the pituitary, triggering a clean GH pulse. Its selectivity avoids the appetite and cortisol effects seen with older secretagogues like GHRP-6.
Key benefitsClean GH pulse without hunger spikes · Better sleep quality and recovery · Mild fat-loss and body-composition support
Side effectsMild headache · Injection-site redness · Light-headedness shortly after dosing
Half-lifeAbout 2 hours
AdministrationSubcutaneous injection, 1–3 times daily
Dosing overview200–300 mcg per dose, often 100–300 mcg before bed
StorageReconstituted vials refrigerated 2–8 °C, stable ~4 weeks
Legal statusNot FDA-approved; compounding restrictions apply in the US. Banned in sport.

Dosing figures reflect published literature and commonly reported community protocols. They are informational only.

Head-to-head comparisons

Each comparison below is its own page with the full attribute table, key differences and shared attributes for that pairing. They are grouped by the category the compounds are indexed under.

GLP-1 receptor agonists

Direct comparisons between the incretin-based compounds most often searched against one another.

Recovery and tissue repair

Pairings between compounds indexed for healing, connective tissue and post-injury recovery.

Growth-hormone axis

Secretagogues and releasing peptides that act on growth-hormone signalling, compared with each other and with adjacent compounds.

Longevity and mitochondrial

Compounds indexed under longevity, cellular and mitochondrial function.

Cognitive and nootropic

Peptides indexed for cognition and mood-related use.

Sexual health

Melanocortin and related compounds indexed for sexual-health use.